This announcement is a separate document:
康辰药业关于向2023年限制性股票激励计划激励对象授予预留限制性股票及调整授予价格的公告
Announcement of Beijing Konruns Pharmaceutical on granting reserved restricted stocks and adjusting the grant price to the restricted stock incentive plan for 2023.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.